No results for ‘’
Mangalam Drugs and Organics Ltd
₹28.76
(0.24%)
Wed, 03 Jun 2026, 06:06 pm
Health Technology
Pharmaceuticals: Major
24.5KMangalam Drugs and Organics Shareholding
| Shareholders | MAR 2026 | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 |
|---|---|---|---|---|---|
| Promoters | 35.65 | 35.64 | 50.30 | 50.30 | 50.30 |
| FII | 0.32 | 0.13 | 0.11 | 0.53 | 0.47 |
| DII | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public | 64.02 | 64.22 | 49.58 | 49.16 | 49.23 |
| Government | 0 | 0 | 0 | 0 | 0 |
Mangalam Drugs and Organics Ltd Shareholding Pattern
The Mangalam Drugs and Organics Ltd shareholding pattern provides detailed insights into how ownership of the company is distributed among promoters, FIIs, DIIs, public investors, and government entities. Tracking the Mangalam Drugs and Organics Ltd shareholding structure helps investors understand institutional confidence, promoter commitment, and overall market sentiment.
Mangalam Drugs and Organics Ltd (NSE: MANGALAM, BSE: 532637) operates in the Health technology sector and Pharmaceuticals: major industry. Monitoring the Mangalam Drugs and Organics Ltd shareholding pattern regularly allows investors to analyze ownership trends and make informed investment decisions.
Mangalam Drugs and Organics Ltd Shareholding Pattern (Latest)
The latest Mangalam Drugs and Organics Ltd shareholding for Mar 2026 is:
- Promoters: 35.65%
- FII: 0.32%
- DII: 0.00%
- Public: 64.02%
- Government: 0%
Promoter holding in Mangalam Drugs and Organics Ltd has increased, indicating strong confidence from company promoters.
Mangalam Drugs and Organics Ltd Promoter Holding Trend
Promoter shareholding plays a crucial role in evaluating management confidence in Mangalam Drugs and Organics Ltd.
- Mar 2026: 35.65%
- Dec 2025: 35.64%
- Sept 2025: 50.30%
- Jun 2025: 50.30%
- Mar 2025: 50.30%
Promoter stake in Mangalam Drugs and Organics Ltd has increased, indicating strong long-term confidence.
Mangalam Drugs and Organics Ltd FII Shareholding Trend
Foreign Institutional Investors (FIIs) reflect global investor sentiment toward Mangalam Drugs and Organics Ltd.
- Mar 2026: 0.32%
- Dec 2025: 0.13%
- Sept 2025: 0.11%
- Jun 2025: 0.53%
- Mar 2025: 0.47%
FII holding in Mangalam Drugs and Organics Ltd has increased recently, indicating rising foreign investor interest.
Mangalam Drugs and Organics Ltd DII Shareholding Trend
Domestic Institutional Investors (DIIs) include mutual funds, banks, and insurance companies.
- Mar 2026: 0.00%
- Dec 2025: 0.00%
- Sept 2025: 0.00%
- Jun 2025: 0.00%
- Mar 2025: 0.00%
DII holdings remain stable, reflecting steady institutional participation.
Mangalam Drugs and Organics Ltd Public Shareholding Trend
Public shareholding represents retail and non-institutional investors.
- Mar 2026: 64.02%
- Dec 2025: 64.22%
- Sept 2025: 49.58%
- Jun 2025: 49.16%
- Mar 2025: 49.23%
Public holding remains stable with consistent retail participation.
Mangalam Drugs and Organics Ltd Government Holding
Government holding in Mangalam Drugs and Organics Ltd currently stands at 0%.
Mangalam Drugs and Organics Ltd operates without significant government ownership.
Mangalam Drugs and Organics Ltd Shareholding Analysis Summary
The Mangalam Drugs and Organics Ltd shareholding pattern highlights the ownership structure and investor confidence in the company. Stable promoter holdings combined with institutional participation often indicate strong fundamentals and long-term growth potential.
Investors should monitor changes in Mangalam Drugs and Organics Ltd shareholding for signals on institutional sentiment and ownership trends.
Regular monitoring of the Mangalam Drugs and Organics Ltd shareholding helps investors understand market confidence, institutional activity, and potential future stock movements.